Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2021 Filed Dec 21, 2021 02:34 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 6 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Living Trust Disclosed balance after: 3,235,287 Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 02:34 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 13,215 | $119.37 | $1,577,474.55 |
DisclosureSEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,001.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $118.8850 to $119.8550. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 02:34 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 12,809 | $118.37 | $1,516,201.33 |
DisclosureSEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 4 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,216.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $117.8700 to $118.8700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 02:34 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,025.82 Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 02:34 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 6,526 | $120.09 | $783,707.34 |
DisclosureSEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,525.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $119.8900 to $120.8200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 02:34 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 45,050 | $21.76 | $980,288.00 |
DisclosureSEC source: 0001225208-21-015166 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,051.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. Read SEC document |
| December 17, 2021 Filed Dec 18, 2021 00:51 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 10,000 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-015136 · doc4.xml · derivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,400 Underlying: Common Stock · 10,000 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2021 Filed Dec 18, 2021 00:51 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 10,000 | $121.24 | $1,212,400.00 |
DisclosureSEC source: 0001225208-21-015136 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,414.5223 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. Read SEC document |
| December 17, 2021 Filed Dec 18, 2021 00:51 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 10,000 | $21.76 | $217,600.00 |
DisclosureSEC source: 0001225208-21-015136 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,414.5223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:41 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,830 | $0.00 Strike: $35.20 | $0.00 |
DisclosureSEC source: 0001225208-21-014811 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,830 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:41 UTC |
Wood Larry LCVP, TAVR
|
SaleCommon Stock | 7,830 | $121.49 | $951,266.70 |
DisclosureSEC source: 0001225208-21-014811 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,432.42 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:41 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionCommon Stock | 7,830 | $35.20 | $275,590.16 |
DisclosureSEC source: 0001225208-21-014811 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,262.42 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. F2 · balance_after: Represents shares transferred to the reporting person's ex-spouse pursuant to a divorce judgement. The securities owned by the ex-spouse are not beneficially owned by the reporting person. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:36 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,050 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-014810 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,200 Underlying: Common Stock · 11,050 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:36 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 10,240 | $121.46 | $1,243,791.36 |
DisclosureSEC source: 0001225208-21-014810 · doc4.xml · nonDerivative · entry 3 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,399.3995 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $120.9100 to $121.9500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:36 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 810 | $122.04 | $98,855.07 |
DisclosureSEC source: 0001225208-21-014810 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,639.3995 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $122.0050 to $122.0700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:36 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,050 | $21.76 | $240,448.00 |
DisclosureSEC source: 0001225208-21-014810 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,449.3995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:27 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,350 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-014809 · doc4.xml · derivative · entry 4 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 6,350 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:27 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
SaleCommon Stock | 5,950 | $121.46 | $722,701.88 |
DisclosureSEC source: 0001225208-21-014809 · doc4.xml · nonDerivative · entry 3 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,026.8935 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $121.01 to $121.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:27 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
SaleCommon Stock | 400 | $122.04 | $48,817.00 |
DisclosureSEC source: 0001225208-21-014809 · doc4.xml · nonDerivative · entry 2 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,976.8935 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $122.01 to $122.09. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 10, 2021 Filed Dec 11, 2021 01:27 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionCommon Stock | 6,350 | $21.76 | $138,176.00 |
DisclosureSEC source: 0001225208-21-014809 · doc4.xml · nonDerivative · entry 1 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,376.8935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 01:21 UTC |
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 100 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-014184 · doc4.xml · derivative · entry 3 Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,880 Underlying: Common Stock · 100 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 01:21 UTC |
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
|
SaleCommon Stock | 100 | $110.58 | $11,058.00 |
DisclosureSEC source: 0001225208-21-014184 · doc4.xml · nonDerivative · entry 2 Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,103.487 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 01:21 UTC |
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
|
Exercise / conversionCommon Stock | 100 | $21.76 | $2,176.00 |
DisclosureSEC source: 0001225208-21-014184 · doc4.xml · nonDerivative · entry 1 Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,203.487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 22:28 UTC |
VALERIANI NICHOLAS JDirector
|
PurchaseCommon Stock | 1,500 | $112.23 | $168,345.00 |
DisclosureSEC source: 0001225208-21-014149 · doc4.xml · nonDerivative · entry 1 VALERIANI NICHOLAS J · CIK 0001263149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,811 Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:31 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 10,000 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-013981 · doc4.xml · derivative · entry 5 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,400 Underlying: Common Stock · 10,000 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:31 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 6,357 | $117.88 | $749,394.31 |
DisclosureSEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 4 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,414.5223 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $117.5790 to $118.4800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:31 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 2,390 | $116.98 | $279,586.26 |
DisclosureSEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,771.5223 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $116.4900 to $117.3600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:31 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 1,253 | $118.87 | $148,947.12 |
DisclosureSEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,161.5223 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $118.5900 to $118.8800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:31 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 10,000 | $21.76 | $217,600.00 |
DisclosureSEC source: 0001225208-21-013981 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,414.5223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 22:38 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,830 | $0.00 Strike: $35.20 | $0.00 |
DisclosureSEC source: 0001225208-21-013769 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,830 Underlying: Common Stock · 7,830 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 22:38 UTC |
Wood Larry LCVP, TAVR
|
SaleCommon Stock | 7,830 | $119.79 | $937,955.70 |
DisclosureSEC source: 0001225208-21-013769 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,133.5508 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 22:38 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionCommon Stock | 7,830 | $35.20 | $275,590.16 |
DisclosureSEC source: 0001225208-21-013769 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,963.5508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 00:45 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 45,050 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-013738 · doc4.xml · derivative · entry 7 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,300 Underlying: Common Stock · 45,050 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 00:45 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Living Trust Disclosed balance after: 3,222,787 Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 00:45 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 18,428 | $119.70 | $2,205,831.60 |
DisclosureSEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 4 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,001.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $118.9400 to $119.9400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 00:45 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 14,122 | $120.17 | $1,697,040.74 |
DisclosureSEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,429.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $119.9500 to $120.4050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 00:45 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,551.82 Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 00:45 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 45,050 | $21.76 | $980,288.00 |
DisclosureSEC source: 0001225208-21-013738 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,051.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 23:10 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,350 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-013694 · doc4.xml · derivative · entry 3 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,050 Underlying: Common Stock · 6,350 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 23:10 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
SaleCommon Stock | 6,350 | $119.40 | $758,190.00 |
DisclosureSEC source: 0001225208-21-013694 · doc4.xml · nonDerivative · entry 2 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,026.8935 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 23:10 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionCommon Stock | 6,350 | $21.76 | $138,176.00 |
DisclosureSEC source: 0001225208-21-013694 · doc4.xml · nonDerivative · entry 1 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,376.8935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 21:31 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,050 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-013644 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,250 Underlying: Common Stock · 11,050 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 21:31 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 6,459 | $116.81 | $754,444.14 |
DisclosureSEC source: 0001225208-21-013644 · doc4.xml · nonDerivative · entry 3 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,399.3995 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $116.40 to $117.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 21:31 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 4,591 | $117.68 | $540,263.83 |
DisclosureSEC source: 0001225208-21-013644 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,858.3995 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $117.42 to $118.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 21:31 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,050 | $21.76 | $240,448.00 |
DisclosureSEC source: 0001225208-21-013644 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,449.3995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. Read SEC document |
| October 18, 2021 Filed Oct 18, 2021 21:00 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 9,741 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-013132 · doc4.xml · derivative · entry 4 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,400 Underlying: Common Stock · 9,741 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2021 Filed Oct 18, 2021 21:00 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 7,138 | $110.24 | $786,883.13 |
DisclosureSEC source: 0001225208-21-013132 · doc4.xml · nonDerivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,414.5223 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $109.6400 to $110.6100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 18, 2021 Filed Oct 18, 2021 21:00 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 2,603 | $110.87 | $288,598.51 |
DisclosureSEC source: 0001225208-21-013132 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,552.5223 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $110.6400 to $110.9100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 18, 2021 Filed Oct 18, 2021 21:00 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 9,741 | $21.76 | $211,964.16 |
DisclosureSEC source: 0001225208-21-013132 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,155.5223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2021. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 20:51 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,830 | $0.00 Strike: $35.20 | $0.00 |
DisclosureSEC source: 0001225208-21-013089 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,660 Underlying: Common Stock · 7,830 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.